Safety and Efficacy of Natalizumab in Combination With Avonex in the Treatment of Multiple Sclerosis
Status:
Completed
Trial end date:
2005-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if natalizumab in combination with AVONEX is safe
and effective in delaying progression of individuals diagnosed with relapsing remitting
Multiple Sclerosis (MS).